DOSE:CC News and Press, Rapid Dose Therapeutics Corp. From 06/02/23

Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) (CSE: DOSE) today announced that it plans to complete a private placement financing (the “ Financing ”) for up to $3,000,000 of gross proceeds, consisting of up to 3,000,000 units (the...

Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) (CSE: DOSE) announces that it has changed its auditor from MNP LLP (“ Former Auditor ”) to SRCO Professional Corporation, Chartered Professional Accountants (“ Successor ...

QuickStrip™ Xylitol and Lidocaine to offer consumers needle-free options for dental procedures Rapid Dose Therapeutics Corp. (“ RDT ”) ( CSE: DOSE ), a Canadian biotechnology company revolutionizing drug delivery through innovation has launched two unique de...

Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) (CSE: DOSE) is pleased to announce that further to its press release dated May 2, 2023, trading in the Company’s common shares has resumed on the Canadian Securities Exchange. About Rapid D...

Toronto, Ontario--(Newsfile Corp. - Le 4 mai/May 2023) - Effective immediately, Rapid Dose Therapeutics Corp. will be reinstated for trading. The Company has rectified the situation that gave rise to the suspension. _________________________________ Avec effet immédiat, Rapid Dose...

IIROC Trade Resumption - DOSE Canada NewsWire VANCOUVER, BC , May 4, 2023 /CNW/ - Trading resumes in: Company: Rapid Dose Therapeutics Corp. CSE Symbol: DOSE All Issues: Yes Resumption (ET): 10:30 AM IIROC can make a decision to impose a tempo...

Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) (CSE: DOSE) is pleased to announce that on May 1, 2023, staff of the Ontario Securities Commission (the “ OSC ”) granted a full revocation of the failure-to-file cease trade order (&#x...

Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) (CSE: DOSE) announces that further to the review by the Ontario Securities Commission (“ OSC ”) of the Company’s continuous disclosure record, and a subsequent request from staf...

Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is announcing changes to its board of directors. Jason Lewis has resigned as a director of...

Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), has filed its financial results for the first three quarters of the 2023 fiscal year. Now that the Company has completed the filing of its audited financial statements for the fiscal year ended Feb...